Thermo Fisher has brought to market easy-to-use, real-time PCR instruments. Designed for mid-throughput, these new systems provide ideal solutions for all users who need a high-performance instrument with features for maximum experiment control. Adding Thermo Fisher's real-time PCR system to the VERSANT kPCR Molecular Solution brings a new level of innovation to the market by providing more flexibility and customization to the molecular laboratory workflow.
"Through our molecular diagnostics systems, we offer a total solution for accurate diagnosis and monitoring," says Fernando Beils, Head of Molecular Diagnostics, Siemens Healthcare. "We are excited to strengthen our dedication to molecular laboratory innovations through our partnership with Thermo Fisher Scientific."
"This agreement underscores our commitment to work with leading molecular diagnostic organizations that share our vision to develop advanced laboratory solutions," said Drew Burch, Head of Licensing and Commercial Supply for Thermo Fisher Scientific. "We are excited to collaborate with Siemens in support of its VERSANT kPCR Molecular Solution as we work to expand our partnerships in the diagnostics space."
About Siemens AG
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of gas and steam turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment - such as computed tomography and magnetic resonance imaging systems - and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2015, which ended on September 30, 2015, Siemens generated revenue of €75.6 billion and net income of €7.4 billion.
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands - Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services - we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.